| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/23/1997 | EP0784631A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/23/1997 | EP0784489A2 Composition use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784478A1 Inhibition of endothelin-1 to reduce inflammatory processes |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/22/1997 | US5650502 Ribozyme analogs having rigid non-nucleotidic linkers |
| 07/22/1997 | US5650316 Uses of triplex forming oligonucleotides for the treatment of human diseases |
| 07/22/1997 | US5650298 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 07/22/1997 | US5650280 Cellubrevin homolog |
| 07/22/1997 | US5650148 Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| 07/22/1997 | US5650096 Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| 07/17/1997 | WO1997025446A1 Recombinase-mediated generation of adenoviral vectors |
| 07/17/1997 | WO1997025426A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/17/1997 | WO1997025424A1 Ob protein receptor and related compositions and methods |
| 07/17/1997 | WO1997025414A1 Delivery of bioactive compounds to an organism |
| 07/17/1997 | WO1997025339A1 Composition and method for delivery of nucleic acids |
| 07/17/1997 | WO1997025338A1 Immune cell cytokine |
| 07/17/1997 | WO1997025072A1 Compositions and methods for therapeutic use |
| 07/17/1997 | WO1997025067A2 Polymers |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | WO1997017937A3 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 07/17/1997 | WO1997012969A3 Fmr1-related protein |
| 07/17/1997 | WO1997009428A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/17/1997 | CA2242964A1 Immune cell cytokine |
| 07/17/1997 | CA2242910A1 Human g-protein coupled receptor |
| 07/17/1997 | CA2242711A1 Delivery of bioactive compounds to an organism |
| 07/17/1997 | CA2242340A1 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/17/1997 | CA2241830A1 Polymers |
| 07/17/1997 | CA2239366A1 Recombinase-mediated generation of adenoviral vectors |
| 07/16/1997 | EP0784094A1 Ribozyme -snRNA chimeric molecules having a catalytic activity for nuclear RNAs |
| 07/16/1997 | EP0784093A1 Osteoprotegerin |
| 07/16/1997 | EP0783586A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 07/16/1997 | EP0783585A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 07/16/1997 | EP0783575A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 07/16/1997 | EP0783573A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 07/16/1997 | EP0783570A1 Finderons and methods of their preparation and use |
| 07/16/1997 | EP0783568A1 Fibroblasts for the treatment of muscular disorders |
| 07/16/1997 | EP0783567A1 Human galactokinase gene |
| 07/16/1997 | EP0783523A1 Gaba a? receptor epsilon subunit |
| 07/16/1997 | EP0783511A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/16/1997 | EP0783509A1 Human transcription factor iia |
| 07/16/1997 | EP0783482A1 Cationic transport reagents |
| 07/16/1997 | EP0783296A1 Novel compositions for the introduction of polyanionic materials into cells |
| 07/16/1997 | EP0586618B1 The use of nucleic acid analogues in diagnostics and analytical procedures |
| 07/16/1997 | CN1154718A Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression |
| 07/15/1997 | US5648478 Tissue-specific enhancer active in prostate |
| 07/15/1997 | US5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications |
| 07/15/1997 | US5648239 Human camp-dependent protein kinase inhibitor homolog |
| 07/15/1997 | US5648238 Human protein kinase C inhibitor homolog |
| 07/15/1997 | US5648226 Isolated peptides derived from tumor rejection antigens, and their use |
| 07/10/1997 | WO1997024572A1 Ceramic packing with channels for thermal and catalytic beds |
| 07/10/1997 | WO1997024453A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
| 07/10/1997 | WO1997024447A1 Immunostimulation mediated by gene-modified dendritic cells |
| 07/10/1997 | WO1997024446A2 Gene delivery vehicle-targeting ligands |
| 07/10/1997 | WO1997024441A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | WO1997024439A1 Gene which enables cancer cells to return to normal |
| 07/10/1997 | WO1997024144A1 Methods of preparing bone marrow stromal cells for use in gene therapy |
| 07/10/1997 | WO1997018305A3 Method to prepare drug-resistant, non-malignant hematopoietic cells |
| 07/10/1997 | WO1997015662A3 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 07/10/1997 | WO1997011682A3 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/10/1997 | WO1997008309A3 Ribozyme therapy for hepatitis b infections |
| 07/10/1997 | CA2240578A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
| 07/10/1997 | CA2238885A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/09/1997 | EP0782862A1 Genetic material containing composition |
| 07/09/1997 | EP0782630A1 Polycystic kidney disease gene |
| 07/09/1997 | EP0782627A1 Genetically altered t-cells |
| 07/09/1997 | EP0782622A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) APO(a)] |
| 07/09/1997 | EP0782619A1 Novel pka-binding proteins and uses thereof |
| 07/09/1997 | CN1154144A Isolated, tyrosinase derived peptides and uses thereof |
| 07/09/1997 | CN1154142A Transgenic fish in the treatment of diabetes |
| 07/08/1997 | US5646265 Process for the preparation of 2'-O-alkyl purine phosphoramidites |
| 07/08/1997 | US5646262 Binds encapsidation sequence of messenger rna intermediate; genetic engineering |
| 07/08/1997 | US5646261 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use |
| 07/08/1997 | US5646185 Administering protein kinase c activator consisting of phorbol ester, diacylglycerol, or thapsigargin to hypoxic cells |
| 07/08/1997 | US5646043 Culturing a hematopoeitic stem cell composition |
| 07/08/1997 | US5646042 C-myb targeted ribozymes |
| 07/08/1997 | US5646040 Mammalian tub gene |
| 07/08/1997 | US5646034 Recombinant adeno-associated virus |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5646021 Finderons and methods of their preparation and use |
| 07/08/1997 | US5646011 Overcoming resistance of tumor cells to chemotheraputic agents, gene expression |
| 07/08/1997 | US5646008 Vertebrate apoptosis gene: compositions and methods |
| 07/08/1997 | US5645999 Assays for compounds that modulate or alter cyclin E activity |
| 07/08/1997 | US5645985 Used for diagnosis to detect viruses or diseased conditions |
| 07/08/1997 | US5645829 Mesothelial cell gene therapy |
| 07/06/1997 | CA2186542A1 Composition and method for delivery of nucleic acids |
| 07/03/1997 | WO1997023639A1 Process for producing biologically active fused proteins |
| 07/03/1997 | WO1997023632A1 A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK |
| 07/03/1997 | WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 07/03/1997 | WO1997023622A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023620A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023614A1 Osteoprotegerin |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | WO1997023610A1 Dna sequences associated with fraxe mental retardation |
| 07/03/1997 | WO1997023607A2 Presentation of antigen, introduced into cells by stimulation of macropinocytosis |
| 07/03/1997 | WO1997023603A1 Method of isolating and growing recombinant eb viruses |
| 07/03/1997 | WO1997023598A2 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 07/03/1997 | WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus |
| 07/03/1997 | WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |